Bioventus Inc.

Bioventus Inc. is a medical device company that develops and provides treatments for pain relief and musculoskeletal conditions. It operates through two reporting segments: U.S. and International. The company organizes its products into three clinical categories: Pain Treatments, Surgical Solutions, and Restorative Therapies. Offerings include hyaluronic acid injections and peripheral nerve stimulation systems, ultrasonic surgical systems and bone graft substitutes, and ultrasound fracture healing devices. Bioventus supplies these products to healthcare providers across physician offices, ambulatory surgical centers, and hospitals.

The company manufactures and assembles most of its medical devices at a production facility in Cordova, Tennessee. It sells products domestically and globally through direct sales personnel, independent representatives, and third-party distributors. Its geographical footprint spans the United States, Canada, Europe, and Japan, with additional regulatory clearances in Australia, New Zealand, Saudi Arabia, Turkey, and the United Arab Emirates. The provided text does not state the location of the company's headquarters.

Summary of the business section of Bioventus's latest annual report, written by StockData.

“As of December 31, 2025, we had approximately 930 employees, none of whom were covered by collective bargaining agreements.”